C07F 9/6561
Containing systems of two or more relevant hetero rings condensed among themselves
Official title: containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
C07F9/6561 (Containing systems of two or more relevant hetero rings condensed among themselves) appears on 2,069 US grants and 2,136 published applications in this corpus.
Search patents in C07F- Granted patents
- 2,069
- Published applications
- 2,136
- Assignees
- 1,041
- Inventors
- 5,882
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 27 | 0 |
| 1977 | 10 | 0 |
| 1978 | 16 | 0 |
| 1979 | 11 | 0 |
| 1980 | 9 | 0 |
| 1981 | 19 | 0 |
| 1982 | 12 | 0 |
| 1983 | 26 | 0 |
| 1984 | 21 | 0 |
| 1985 | 23 | 0 |
| 1986 | 15 | 0 |
| 1987 | 14 | 0 |
| 1988 | 13 | 0 |
| 1989 | 19 | 0 |
| 1990 | 16 | 0 |
| 1991 | 25 | 0 |
| 1992 | 33 | 0 |
| 1993 | 23 | 0 |
| 1994 | 26 | 0 |
| 1995 | 24 | 0 |
| 1996 | 42 | 0 |
| 1997 | 58 | 0 |
| 1998 | 60 | 0 |
| 1999 | 51 | 0 |
| 2000 | 38 | 0 |
| 2001 | 39 | 9 |
| 2002 | 43 | 40 |
| 2003 | 38 | 55 |
| 2004 | 25 | 44 |
| 2005 | 22 | 65 |
| 2006 | 25 | 79 |
| 2007 | 24 | 53 |
| 2008 | 40 | 54 |
| 2009 | 40 | 79 |
| 2010 | 49 | 61 |
| 2011 | 36 | 64 |
| 2012 | 63 | 60 |
| 2013 | 55 | 87 |
| 2014 | 66 | 86 |
| 2015 | 85 | 106 |
| 2016 | 75 | 110 |
| 2017 | 93 | 98 |
| 2018 | 65 | 107 |
| 2019 | 93 | 104 |
| 2020 | 80 | 102 |
| 2021 | 60 | 104 |
| 2022 | 82 | 107 |
| 2023 | 59 | 132 |
| 2024 | 68 | 123 |
| 2025 | 68 | 116 |
| 2026 | 45 | 91 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07F 9/65616Containing the ring system [image cpc-sch-c07f-1006.gif] having three or more than three610
- C07F 9/65613Containing the ring system [image cpc-sch-c07f-1004.gif] optionally with an additional double bond69
- C07F 9/65611Containing the ring system [image cpc-sch-c07f-1003.gif] optionally with an additional double bond68
- C07F 9/65615Containing a spiro condensed ring system of the formula [image cpc-sch-c07f-1005.gif] where18
- C07F 9/65618Containing the ring system, [image cpc-sch-c07f-1007.gif] e.g. flavins or analogues4
Recent patents
- Solid supports and phosphoramidite building blocks for oligonucleotide conjugates15 Sep 2026US 12,735,387 B2AM Chemicals LLC
- Prodrugs for sustained releasing therapeutic agents and uses thereof8 Sep 2026US 12,729,186 B2Liangjiang Medicine Co., Ltd.
- TRPC5 inhibitor compounds and intermediate thereof, preparation method therefor and use thereof8 Sep 2026US 12,729,204 B2Wuhan Ll Science and Technology Development Co., Ltd.
- Chiral synthons for the synthesis of chiral phosphorothioates25 Aug 2026US 12,715,885 B2Boehringer Ingelheim International GmbH
- STAT6 modulators and uses thereof18 Aug 2026US 12,709,628 B2Recludix Pharma, Inc.
- Long-Lived Gadolinium Based Tumor Targeted Imaging and Therapy Agents8 Oct 2026US 2026/0306634 A1Wisconsin Alumni Research Foundation
- Stat degraders and uses thereof8 Oct 2026US 2026/0308185 A1Recludix Pharma, Inc.
- Stat degraders and uses thereof8 Oct 2026US 2026/0308186 A1Recludix Pharma, Inc.
- Conjugates including a detectable moiety1 Oct 2026US 2026/0297063 A1Ventana Medical Systems, Inc.
- Inhibitors of cyclin-dependent kinase (cdk) 12 and/or cdk13 and uses thereof1 Oct 2026US 2026/0297091 A1Insilico Medicine IP Limited
Most cited
By later US patents
- Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediates468US 5,700,920 ANovartis AG · 1997
- Phosphoramidite derivatives, their preparation and the use thereof in the incorporation of reporter groups on synthetic oligonucleotides421US 5,567,811 AAmersham International plc · 1996
- Acyclic nucleoside analogs and oligonucleotide sequences containing them413US 5,576,427 ASterling Winthrop Inc. · 1996
- Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediates409US 5,610,300 ACiba-Geigy Corporation · 1997
- Alkynylamino-nucleotides340US 5,047,519 AE. I. Du Pont de Nemours and Company · 1991